Recent advances of light-mediated theranostics

Theranostics

Volumn 6, Issue 13, 2016, Pages 2439-2457

  Ai, Xiangzhao ^a   Mu, Jing ^a   Xing, Bengang ^a,b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b INSTITUTE OF MATERIALS RESEARCH AND ENGINEERING   (Singapore)

Author keywords

Cerenkov radiation; Multifunctional nanomaterials; Near infrared light; Photoacoustic; Precision theranostics

Indexed keywords

DOXORUBICIN; NANOCARRIER; NANOMATERIAL; NANOPARTICLE; REAGENT;

BIOACCUMULATION; BIOLOGICAL MONITORING; BIOLUMINESCENCE; BIOMEDICINE; CANCER THERAPY; DIAGNOSTIC TEST; DRUG DELIVERY SYSTEM; HUMAN; ILLUMINATION; IMAGING SYSTEM; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; ISOMERIZATION; LIGHT EXPOSURE; LIGHT MEDIATED THERANOSTICS; MALIGNANT NEOPLASTIC DISEASE; MINIMALLY INVASIVE PROCEDURE; NANOTECHNOLOGY; NONHUMAN; PHOTOACOUSTICS; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; PHOTOTHERMAL THERAPY; POSITRON EMISSION TOMOGRAPHY; RADIATION EXPOSURE; REVIEW; SOLUBILITY; THERANOSTIC NANOMEDICINE; ULTRAVIOLET RADIATION; INFRARED RADIATION; MOLECULARLY TARGETED THERAPY; PROCEDURES; THERAPEUTIC USE; TRENDS;

HUMANS; INFRARED RAYS; MOLECULAR TARGETED THERAPY; PHOTOTHERAPY; THERANOSTIC NANOMEDICINE;

EID: 84999711649     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.16088     Document Type: Review

References (206)

1. Reichard CA, Stephenson AJ, Klein EA. Applying precision medicine to the active surveillance of prostate cancer. Cancer. 2015; 121: 3403-11.
2. Friedman AA, Letai A, Fisher DE, Flaherty KT. Precision medicine for cancer with next-generation functional diagnostics. Nat Rev Cancer. 2015; 15: 747-56.
3. Arnedos M, Vicier C, Loi S, Lefebvre C, Michiels S, Bonnefoi H, et al. Precision medicine for metastatic breast cancer-limitations and solutions. Nat Rev Clin Oncol. 2015; 12: 693-704.
4. Lloyd KC, Meehan T, Beaudet A, Murray S, Svenson K, McKerlie C, et al. Precision medicine: Look to the mice. Science. 2015; 349: 390.
5. Mahoney KM, Rennert PD, Freeman GJ. Combination cancer immunotherapy and new immunomodulatory targets. Nat Rev Drug Discov. 2015; 14: 561-84.
6. Melero I, Berman DM, Aznar MA, Korman AJ, Perez Gracia JL, Haanen J. Evolving synergistic combinations of targeted immunotherapies to combat cancer. Nat Rev Cancer. 2015; 15: 457-72.
7. Van Kessel KE, Zuiverloon TC, Alberts AR, Boormans JL, Zwarthoff EC. Targeted therapies in bladder cancer: an overview of in vivo research. Nat Rev Urol. 2015; 12: 681-94.
8. Blum AP, Kammeyer JK, Rush AM, Callmann CE, Hahn ME, Gianneschi NC. Stimuli-responsive nanomaterials for biomedical applications. J Am Chem Soc. 2015; 137: 2140-54.
9. Thambi T, Park JH, Lee DS. Stimuli-responsive polymersomes for cancer therapy. Biomater Sci. 2016; 4: 55-69.
10. Jhaveri A, Deshpande P, Torchilin V. Stimuli-sensitive nanopreparations for combination cancer therapy. J Control Release. 2014; 190: 352-70.
11. Bansal A, Zhang Y. Photocontrolled nanoparticle delivery systems for biomedical applications. Acc Chem Res. 2014; 47: 3052-60.
12. Li Y, Xiao K, Zhu W, Deng W, Lam KS. Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers. Adv Drug Deliv Rev. 2014; 66: 58-73.
13. Huang P, Lin J, Wang X, Wang Z, Zhang C, He M, et al. Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv Mater. 2012; 24: 5104-10.
14. Yang X, Liu X, Liu Z, Pu F, Ren J, Qu X. Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles. Adv Mater. 2012; 24: 2890-5.
15. Ding X, Liow CH, Zhang M, Huang R, Li C, Shen H, et al. Surface plasmon resonance enhanced light absorption and photothermal therapy in the second near-infrared window. J Am Chem Soc. 2014; 136: 15684-93.
16. Vijayaraghavan P, Liu CH, Vankayala R, Chiang CS, Hwang KC. Designing multi-branched gold nanoechinus for nir light activated dual modal photodynamic and photothermal therapy in the second biological window. Adv Mater. 2014; 26: 6689-95.
17. Kolemen S, Ozdemir T, Lee D, Kim GM, Karatas T, Yoon J, et al. Remote-controlled release of singlet oxygen by the plasmonic heating of endoperoxide-modified gold nanorods: towards a paradigm change in photodynamic therapy. Angew Chem Int Ed. 2016; 55: 3606-10.
18. Sun M, Xu L, Ma W, Wu X, Kuang H, Wang L, et al. Hierarchical plasmonic nanorods and upconversion core-satellite nanoassemblies for multimodal imaging-guided combination phototherapy. Adv Mater. 2015; 28: 898-904.
19. Tian G, Zhang X, Gu Z, Zhao Y. Recent advances in upconversion nanoparticles-based multifunctional nanocomposites for combined cancer therapy. Adv Mater. 2015; 27: 7692-712.
20. Zhao JY, Chen G, Gu YP, Cui R, Zhang ZL, Yu ZL, et al. Ultrasmall magnetically engineered Ag2Se quantum dots for instant efficient labeling and whole-body high-resolution multimodal real-time tracking of cell-derived microvesicles. J Am Chem Soc. 2016; 138: 1893-903.
21. Hong G, Robinson JT, Zhang Y, Diao S, Antaris AL, Wang Q, et al. In vivo fluorescence imaging with Ag2S quantum dots in the second near-infrared region. Angew Chem Int Ed. 2012; 124: 9956-9.
22. Ge J, Lan M, Zhou B, Liu W, Guo L, Wang H, et al. A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation. Nat Commun. 2014; 5: 4596-5004.
23. Fadel TR, Sharp FA, Vudattu N, Ragheb R, Garyu J, Kim D, et al. A carbon nanotube-polymer composite for T-cell therapy. Nature Nanotech. 2014; 9: 639-47.
24. Tian J, Ding L, Ju H, Yang Y, Li X, Shen Z, et al. A multifunctional nanomicelle for real-time targeted imaging and precise near-infrared cancer therapy. Angew Chem Int Ed. 2014; 53: 9544-9.
25. Xiao Q, Zheng X, Bu W, Ge W, Zhang S, Chen F, et al. A core/satellite multifunctional nanotheranostic for in vivo imaging and tumor eradication by radiation/photothermal synergistic therapy. J Am Chem Soc. 2013; 135: 13041-8.
26. Nomoto T, Fukushima S, Kumagai M, Machitani K, Matsumoto Y, Oba M, et al. Three-layered polyplex micelle as a multifunctional nanocarrier platform for light-induced systemic gene transfer. Nat Commun. 2014; 5: 3545-55.
27. Shen J, Chen G, Vu AM, Fan W, Bilsel OS, Chang CC, et al. Engineering the upconversion nanoparticle excitation wavelength: cascade sensitization of tri-doped upconversion colloidal nanoparticles at 800 nm. Adv Opt Mater. 2013; 1: 644-50.
28. Kobayashi H, Ogawa M, Alford R, Choyke PL, Urano Y. New strategies for fluorescent probe design in medical diagnostic imaging. Chem Rev. 2009; 110: 2620-40.
29. Zhang Z, Wang J, Chen C. Near-infrared light-mediated nanoplatforms for cancer thermo-chemotherapy and optical imaging. Adv Mater. 2013; 25: 3869-80.
30. Hudson DE, Hudson DO, Wininger JM, Richardson BD. Penetration of laser light at 808 and 980 nm in bovine tissue samples. Photomed Laser Surg. 2013; 31: 163-8.
31. Campos A, Guterres Y, Bauer EB, Moreira MC. High brightness LEDs supplied by electronics converters used in tissue healing and cell rejuvenation. In: Serra PA, ed. Advances in Bioengineering. Croatia: InTech; 2015: 231-51.
32. Barth BM, Altinoglu E, Shanmugavelandy SS, Kaiser JM, Crespo-Gonzalez D, DiVittore NA, et al. Targeted indocyanine-green-loaded calcium phosphosilicate nanoparticles for in vivo photodynamic therapy of leukemia. ACS Nano. 2011; 5: 5325-37.
33. Deng K, Hou Z, Deng X, Yang P, Li C, Lin J. Enhanced Antitumor Efficacy by 808 nm Laser-induced synergistic photothermal and photodynamic therapy based on a indocyanine-green-attached W18O49 nanostructure. Adv Funct Mater. 2015; 25: 7280-90.
34. Jing T, Fu L, Liu L, Yan L. A reduction-responsive polypeptide nanogel encapsulating NIR photosensitizer for imaging guided photodynamic therapy. Polymer Chemistry. 2016; 7: 951-7.
35. Shanmugam V, Selvakumar S, Yeh C-S. Near-infrared light-responsive nanomaterials in cancer therapeutics. Chem Soc Rev. 2014; 43: 6254-87.
36. Melancon MP, Zhou M, Li C. Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res. 2011; 44: 947-56.
37. Maji SK, Sreejith S, Joseph J, Lin M, He T, Tong Y, et al. Upconversion nanoparticles as a contrast agent for photoacoustic imaging in live mice. Adv Mater. 2014; 26: 5633-8.
38. Kim JW, Galanzha EI, Shashkov EV, Moon HM, Zharov VP. Golden carbon nanotubes as multimodal photoacoustic and photothermal high-contrast molecular agents. Nature Nanotech. 2009; 4: 688-94.
39. Thorek DL, Riedl CC, Grimm J. Clinical Cerenkov luminescence imaging of 18F-FDG. J Nucl Med. 2014; 55: 95-8.
40. Fan NC, Cheng FY, Ho JA, Yeh CS. Photocontrolled targeted drug delivery: photocaged biologically active folic acid as a light-responsive tumor-targeting molecule. Angew Chem Int Ed. 2012; 51: 8806-10.
41. Brown PK, Qureshi AT, Moll AN, Hayes DJ, Monroe WT. Silver nanoscale antisense drug delivery system for photoactivated gene silencing. ACS Nano. 2013; 7: 2948-59.
42. Matsushita-Ishiodori Y, Ohtsuki T. Photoinduced RNA interference. Acc Chem Res. 2012; 45: 1039-47.
43. Jiang J, Tong X, Zhao Y. A new design for light-breakable polymer micelles. J Am Chem Soc. 2005; 127: 8290-1.
44. Jin Q, Mitschang F, Agarwal S. Biocompatible drug delivery system for photo-triggered controlled release of 5-Fluorouracil. Biomacromolecules. 2011; 12: 3684-91.
45. Karthik S, Puvvada N, Kumar BN, Rajput S, Pathak A, Mandal M, et al. Photoresponsive coumarin-tethered multifunctional magnetic nanoparticles for release of anticancer drug. ACS Appl Mater Interfaces. 2013; 5: 5232-8.
46. Shao Q, Jiang T, Ren G, Cheng Z, Xing B. Photoactivable bioluminescent probes for imaging luciferase activity. Chem Commun. 2009: 4028-30.
47. Hwang K, Wu P, Kim T, Lei L, Tian S, Wang Y, et al. Photocaged DNAzymes as a general method for sensing metal ions in living cells. Angew Chem Int Ed. 2014; 53: 13798-802.
48. Martínez-Carmona M, Baeza A, Rodriguez-Milla MA, García-Castro J, Vallet-Regí M. Mesoporous silica nanoparticles grafted with a light-responsive protein shell for highly cytotoxic antitumoral therapy. J Mater Chem B. 2015; 3: 5746-52.
49. Hu X, Tian J, Liu T, Zhang G, Liu S. Photo-triggered release of caged camptothecin prodrugs from dually responsive shell cross-linked micelles. Macromolecules. 2013; 46: 6243-56.
50. Dcona MM, Mitra D, Goehe RW, Gewirtz DA, Lebman DA, Hartman MC. Photocaged permeability: a new strategy for controlled drug release. Chem Commun. 2012; 48: 4755-7.
51. Tan X, Li BB, Lu X, Jia F, Santori C, Menon P, et al. Light-triggered, self-immolative nucleic Acid-drug nanostructures. J Am Chem Soc. 2015; 137: 6112-5.
52. Laprell L, Repak E, Franckevicius V, Hartrampf F, Terhag J, Hollmann M, et al. Optical control of NMDA receptors with a diffusible photoswitch. Nat Commun. 2015; 6: 8076-87.
53. Tarn D, Ferris DP, Barnes JC, Ambrogio MW, Stoddart JF, Zink JI. A reversible light-operated nanovalve on mesoporous silica nanoparticles. Nanoscale. 2014; 6: 3335-43.
54. Zhao Q, Wang Y, Yan Y, Huang J. Smart nanocarrier: self-assembly of bacteria-like vesicles with photoswitchable cilia. ACS Nano. 2014; 8: 11341-9.
55. Yuan Q, Zhang Y, Chen T, Lu D, Zhao Z, Zhang X, et al. Photon-manipulated drug release from amesoporousnanocontainer controlled by azobenzene-modified nucleic acid. ACS Nano. 2012; 6: 6337-44.
56. Wang X, Hu J, Liu G, Tian J, Wang H, Gong M, et al. Reversibly switching bilayer permeability and release modules of photochromic polymersomes stabilized by cooperative noncovalent interactions. J Am Chem Soc. 2015; 137: 15262-75.
57. Chen S, Jiang F, Cao Z, Wang G, Dang ZM. Photo, pH, and thermo triple-responsive spiropyran-based copolymer nanoparticles for controlled release. Chem Commun. 2015; 51: 12633-6.
58. Mengel AK, He B, Wenger OS. A triarylamine-triarylborane dyad with a photochromic dithienylethene bridge. J Org Chem. 2012; 77: 6545-52.
59. Cui X, Zhao J, Zhou Y, Ma J, Zhao Y. Reversible photoswitching of triplet-triplet annihilation upconversion using dithienylethene photochromic switches. J Am Chem Soc. 2014; 136: 9256-9.
60. Chen L, Wang W, Su B, Wen Y, Li C, Zhou Y, et al. A light-responsive release platform by controlling the wetting behavior of hydrophobic surface. ACS Nano. 2014; 8: 744-51.
61. Tong R, Hemmati HD, Langer R, Kohane DS. Photoswitchable nanoparticles for triggered tissue penetration and drug delivery. J Am Chem Soc. 2012; 134: 8848-55.
62. Priestman MA, Shell TA, Sun L, Lee HM, Lawrence DS. Merging of confocal and caging technologies: selective three-color communication with profluorescent reporters. Angew Chem Int Ed. 2012; 51: 7684-7.
63. Shell TA, Lawrence DS. Vitamin B12: a tunable, long wavelength, light-responsive platform for launching therapeutic agents. Acc Chem Res. 2015; 48: 2866-74.
64. Shell TA, Shell JR, Rodgers ZL, Lawrence DS. Tunable visible and near-IR photoactivation of light-responsive compounds by using fluorophores as light-capturing antennas. Angew Chem Int Ed. 2014; 53: 875-8.
65. McKenzie TG, Wong EHH, Fu Q, Sulistio A, Dunstan DE, Qiao GG. Controlled formation of star polymer nanoparticles via visible light photopolymerization. ACS Macro Letters. 2015; 4: 1012-6.
66. McKenzie TG, Fu Q, Wong EHH, Dunstan DE, Qiao GG. Visible light mediated controlled radical polymerization in the absence of exogenous radical sources or catalysts. Macromolecules. 2015; 48: 3864-72.
67. Fry Nl, Mascharak PK. Photoactive ruthenium nitrosyls as NO donors: how to sensitize them toward visible light. Acc Chem Res. 2011; 44: 289-98.
68. Barragan F, Lopez-Senin P, Salassa L, Betanzos-Lara S, Habtemariam A, Moreno V, et al. Photocontrolled DNA binding of a receptor-targeted organometallic ruthenium(II) complex. J Am Chem Soc. 2011; 133: 14098-108.
69. Leonidova A, Pierroz V, Rubbiani R, Lan Y, Schmitz AG, Kaech A, et al. Photo-induced uncaging of a specific Re (I) organometallic complex in living cells. Chem Sci. 2014; 5: 4044-56.
70. Sgambellone MA, David A, Garner RN, Dunbar KR, Turro C. Cellular toxicity induced by the photorelease of a caged bioactive molecule: design of a potential dual-action Ru(II) complex. J Am Chem Soc. 2013; 135: 11274-82.
71. Howerton BS, Heidary DK, Glazer EC. Strained ruthenium complexes are potent light-activated anticancer agents. J Am Chem Soc. 2012; 134: 8324-7.
72. Shiao YS, Chiu HH, Wu PH, Huang YF. Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery. ACS Appl Mater Interfaces. 2014; 6: 21832-41.
73. Griepenburg JC, Sood N, Vargo KB, Williams D, Rawson J, Therien MJ, et al. Caging metal ions with visible light-responsive nanopolymersomes. Langmuir. 2015; 31: 799-807.
74. Jia L, Zhou T, Xu J, Xu Z, Zhang M, Wang Y, et al. Visible light-induced lanthanide polymer nanocomposites based on clays for bioimaging applications. J Mater Sci. 2015; 51: 1324-32.
75. Frasconi M, Liu Z, Lei J, Wu Y, Strekalova E, Malin D, et al. Photoexpulsion of surface-grafted ruthenium complexes and subsequent release of cytotoxic cargos to cancer cells from mesoporous silica nanoparticles. J Am Chem Soc. 2013; 135: 11603-13.
76. Xu J, Zhou X, Gao Z, Song YY, Schmuki P. Visible-light-triggered drug release from TiO2 nanotube arrays: a controllable antibacterial platform. Angew Chem Int Ed. 2016; 128: 603-7.
77. Luo YL, Shiao YS, Huang YF. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy. ACS Nano. 2011; 5: 7796-804.
78. Schwarz A, Stander S, Berneburg M, Bohm M, Kulms D, van Steeg H, et al. Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat Cell Biol. 2002; 4: 26-31.
79. Zirkin S, Fishman S, Sharim H, Michaeli Y, Don J, Ebenstein Y. Lighting up individual DNA damage sites by in vitro repair synthesis. J Am Chem Soc. 2014; 136: 7771-6.
80. Carling CJ, Boyer JC, Branda NR. Remote-control photoswitching using NIR light. J Am Chem Soc. 2009; 131: 10838-9.
81. Wu W, Yao L, Yang T, Yin R, Li F, Yu Y. NIR-light-induced deformation of cross-linked liquid-crystal polymers using upconversion nanophosphors. J Am Chem Soc. 2011; 133: 15810-3.
82. 3+))-based upconversion nanomaterials for drug delivery. Chem Soc Rev. 2015; 44: 1416-48.
83. Dong H, Du SR, Zheng XY, Lyu GM, Sun LD, Li LD, et al. Lanthanide nanoparticles: from design toward bioimaging and therapy. Chem Rev. 2015; 115: 10725-815.
84. Shen J, Zhao L, Han G. Lanthanide-doped upconverting luminescent nanoparticle platforms for optical imaging-guided drug delivery and therapy. Adv Drug Deliv Rev. 2013; 65: 744-55.
85. Luo D, Carter KA, Miranda D, Lovell JF. Chemophototherapy: An Emerging Treatment Option for Solid Tumors. Adv Sci. 2016 in press. DOI 10.1002/advs.201600106.
86. Bansal A, Zhang Y. Photocontrolled nanoparticle delivery systems for biomedical applications. Acc Chem Res. 2014; 47: 3052-60.
87. Xia Y, Li W, Cobley CM, Chen J, Xia X, Zhang Q, et al. Gold nanocages: from synthesis to theranostic applications. Acc Chem Res. 2011; 44: 914-24.
88. Yang X, Liu Z, Li Z, Pu F, Ren J, Qu X. Near-infrared-controlled, targeted hydrophobic drug-delivery system for synergistic cancer therapy. Chem Eur J. 2013; 19: 10388-94.
89. Luo D, Carter KA, Razi A, Geng J, Shao S, Giraldo D, et al. Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release. Biomaterials. 2016; 75: 193-202.
90. Carter KA, Shao S, Hoopes MI, Luo D, Ahsan B, Grigoryants VM, et al. Porphyrin-phospholipid liposomes permeabilized by near-infrared light. Nat Commun. 2014; 5: 3546-57.
91. Lu Y, Lu J, Zhao J, Cusido J, Raymo FM, Yuan J, et al. On-the-fly decoding luminescence lifetimes in the microsecond region for lanthanide-encoded suspension arrays. Nat Commun. 2014; 5: 3741-9.
92. Lu Y, Zhao J, Zhang R, Liu Y, Liu D, Goldys EM, et al. Tunable lifetime multiplexing using luminescent nanocrystals. Nature Photon. 2014; 8: 32-6.
93. Liu D, Xu X, Du Y, Qin X, Zhang Y, Ma C, et al. Three-dimensional controlled growth of monodisperse sub-50 [thinsp] nm heterogeneous nanocrystals. Nat Commun. 2016; 7: 10254-62.
94. Dong H, Sun L-D, Yan C-H. Energy transfer in lanthanide upconversion studies for extended optical applications. Chem Soc Rev. 2015; 44: 1608-34.
95. Li X, Zhang F, Zhao D. Lab on upconversion nanoparticles: optical properties and applications engineering via designed nanostructure. Chem Soc Rev. 2015; 44: 1346-78.
96. Zheng W, Huang P, Tu D, Ma E, Zhu H, Chen X. Lanthanide-doped upconversion nano-bioprobes: electronic structures, optical properties, and biodetection. Chem Soc Rev. 2015; 44: 1379-415.
97. Zheng X, Zhu X, Lu Y, Zhao J, Feng W, Jia G, et al. High-contrast visualization of upconversion luminescence in mice using time-gating approach. Anal Chem. 2016; 88: 3449-54.
98. Tsang MK, Bai G, Hao J. Stimuli responsive upconversion luminescence nanomaterials and films for various applications. Chem Soc Rev. 2015; 44: 1585-607.
99. Idris NM, Jayakumar MK, Bansal A, Zhang Y. Upconversion nanoparticles as versatile light nanotransducers for photoactivation applications. Chem Soc Rev. 2015; 44: 1449-78.
100. Chen G, Qiu H, Prasad PN, Chen X. Upconversion nanoparticles: design, nanochemistry, and applications in theranostics. Chem Rev. 2014; 114: 5161-214.
101. Carling CJ, Nourmohammadian F, Boyer JC, Branda NR. Remote-control photorelease of caged compounds using near-infrared light and upconverting nanoparticles. Angew Chem Int Ed. 2010; 49: 3782-5.
102. Yang Y, Shao Q, Deng R, Wang C, Teng X, Cheng K, et al. In vitro and in vivo uncaging and bioluminescence imaging by using photocaged upconversion nanoparticles. Angew Chem Int Ed. 2012; 51: 3125-9.
103. Yang Y, Velmurugan B, Liu X, Xing B. NIR photoresponsive crosslinked upconverting nanocarriers toward selective intracellular drug release. Small. 2013; 9: 2937-44.
104. Dai Y, Xiao H, Liu J, Yuan Q, Ma P, Yang D, et al. In vivo multimodality imaging and cancer therapy by near-infrared light-triggered trans-platinum pro-drug-conjugated upconverison nanoparticles. J Am Chem Soc. 2013; 135: 18920-9.
105. Min Y, Li J, Liu F, Yeow EK, Xing B. Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles. Angew Chem Int Ed. 2014; 53: 1012-6.
106. Liu J, Bu W, Pan L, Shi J. NIR-triggered anticancer drug delivery by upconverting nanoparticles with integrated azobenzene-modified mesoporous silica. Angew Chem Int Ed. 2013; 52: 4375-9.
107. Li W, Chen Z, Zhou L, Li Z, Ren J, Qu X. Noninvasive and reversible cell adhesion and detachment via single-wavelength near-infrared laser mediated photoisomerization. J Am Chem Soc. 2015; 137: 8199-205.
108. Chen H, Zhang X, Dai S, Ma Y, Cui S, Achilefu S, et al. Multifunctional gold nanostar conjugates for tumor imaging and combined photothermal and chemo-therapy. Theranostics. 2013; 3: 633-49.
109. Meng Z, Wei F, Wang R, Xia M, Chen Z, Wang H, et al. NIR-laser-switched in vivo smart nanocapsules for synergic photothermal and chemotherapy of tumors. Adv Mater. 2016; 28: 245-53.
110. Liu T, Wang C, Gu X, Gong H, Cheng L, Shi X, et al. Drug delivery with PEGylated MoS2 nano-sheets for combined photothermal and chemotherapy of cancer. Adv Mater. 2014; 26: 3433-40.
111. Kim H, Lee D, Kim J, Kim T, Kim WJ. Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide. ACS Nano. 2013; 7: 6735-46.
112. Jang H, Kim YK, Huh H, Min DH. Facile synthesis and intraparticle self-catalytic oxidation of dextran-coated hollow Au-Ag nanoshell and its application for chemo-thermotherapy. ACS Nano. 2014; 8: 467-75.
113. Shen S, Tang H, Zhang X, Ren J, Pang Z, Wang D, et al. Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation. Biomaterials. 2013; 34: 3150-8.
114. Song J, Yang X, Jacobson O, Lin L, Huang P, Niu G, et al. Sequential drug release and enhanced photothermal and photoacoustic effect of hybrid reduced graphene oxide-loaded ultrasmall gold nanorod vesicles for cancer therapy. ACS nano. 2015; 9: 9199-209.
115. Tang Y, Hu H, Zhang MG, Song J, Nie L, Wang S, et al. An aptamer-targeting photoresponsive drug delivery system using "off-on" graphene oxide wrapped mesoporous silica nanoparticles. Nanoscale. 2015; 7: 6304-10.
116. Li X, Takashima M, Yuba E, Harada A, Kono K. PEGylated PAMAM dendrimer-doxorubicin conjugate-hybridized gold nanorod for combined photothermal-chemotherapy. Biomaterials. 2014; 35: 6576-84.
117. Liao J, Li W, Peng J, Yang Q, Li H, Wei Y, et al. Combined cancer photothermal-chemotherapy based on doxorubicin/gold nanorod-loaded polymersomes. Theranostics. 2015; 5: 345-56.
118. Delcea M, Sternberg N, Yashchenok AM, Georgieva R, Bäumler H, Möhwald H, et al. Nanoplasmonics for dual-molecule release through nanopores in the membrane of red blood cells. ACS Nano. 2012; 6: 4169-80.
119. Yavuz MS, Cheng Y, Chen J, Cobley CM, Zhang Q, Rycenga M, et al. Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nature Mater. 2009; 8: 935-9.
120. Li WP, Liao PY, Su CH, Yeh CS. Formation of oligonucleotide-gated silica shell-coated Fe(3)O(4)-Au core-shell nanotrisoctahedra for magnetically targeted and near-infrared light-responsive theranostic platform. J Am Chem Soc. 2014; 136: 10062-75.
121. Zou W, Visser C, Maduro JA, Pshenichnikov MS, Hummelen JC. Broadband dye-sensitized upconversion of near-infrared light. Nature Photon. 2012; 6: 560-4.
122. Ai F, Ju Q, Zhang X, Chen X, Wang F, Zhu G. A core-shell-shell nanoplatform upconverting near-infrared light at 808 nm for luminescence imaging and photodynamic therapy of cancer. Sci Rep. 2015; 5: 10785-96.
123. Hu J, Tang Y, Elmenoufy AH, Xu H, Cheng Z, Yang X. Nanocomposite-based photodynamic therapy strategies for deep tumor treatment. Small. 2015; 11: 5860-87.
124. Lucky SS, Soo KC, Zhang Y. Nanoparticles in photodynamic therapy. Chem Rev. 2015; 115: 1990-2042.
125. Yang Y, Guo Q, Chen H, Zhou Z, Guo Z, Shen Z. Thienopyrrole-expanded BODIPY as a potential NIR photosensitizer for photodynamic therapy. Chem Commun. 2013; 49: 3940-2.
126. Mehraban N, Freeman HS. Developments in PDT sensitizers for increased selectivity and singlet oxygen production. Materials. 2015; 8: 4421-56.
127. Mikkilä J, Anaya-Plaza E, Liljeström V, Caston JR, Torres T, Escosura Asdl, et al. Hierarchical organization of organic dyes and protein cages into photoactive crystals. ACS nano. 2015; 10: 1565-71.
128. Yuan A, Tang X, Qiu X, Jiang K, Wu J, Hu Y. Activatable photodynamic destruction of cancer cells by NIR dye/photosensitizer loaded liposomes. Chem Commun. 2015; 51: 3340-2.
129. Ding X, Han BH. Metallophthalocyanine-based conjugated microporous polymers as highly efficient photosensitizers for singlet oxygen generation. Angew Chem Int Ed. 2015; 54: 6536-9.
130. Wang C, Cheng L, Liu Z. Upconversion nanoparticles for photodynamic therapy and other cancer therapeutics. Theranostics. 2013; 3: 317-30.
131. Cheng Y, Doane TL, Chuang CH, Ziady A, Burda C. Near infrared light-triggered drug generation and release from gold nanoparticle carriers for photodynamic therapy. Small. 2014; 10: 1799-804.
132. Ge J, Lan M, Zhou B, Liu W, Guo L, Wang H, et al. A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation. Nat Commun. 2014; 5: 4596-5004.
133. Zhang P, Steelant W, Kumar M, Scholfield M. Versatile photosensitizers for photodynamic therapy at infrared excitation. J Am Chem Soc. 2007; 129: 4526-7.
134. Idris NM, Gnanasammandhan MK, Zhang J, Ho PC, Mahendran R, Zhang Y. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat Med. 2012; 18: 1580-5.
135. Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer. 2004; 4: 437-47.
136. Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011; 11: 393-410.
137. Liu Y, Liu Y, Bu W, Cheng C, Zuo C, Xiao Q, et al. Hypoxia induced by upconversion-based photodynamic therapy: towards highly effective synergistic bioreductive therapy in tumors. Angew Chem Int Ed. 2015; 54: 8105-9.
138. Lu S, Tu D, Hu P, Xu J, Li R, Wang M, et al. Multifunctional nano-bioprobes based on rattle-structured upconverting luminescent nanoparticles. Angew Chem Int Ed Engl. 2015; 54: 7915-9.
139. 3+-sensitized upconversion nanophosphors: efficient in vivo bioimaging probes with minimized heating effect. ACS Nano. 2013; 7: 7200-6.
140. 3+-sensitized nanoparticles. Adv Mater. 2014; 26: 2831-7.
141. 3+-sensitized core-shell nanoparticles. J Am Chem Soc. 2013; 135: 12608-11.
142. 3+ sensitized up/down converting dual-mode nanomaterials for efficient in-vitro and in-vivo bioimaging excited at 800 nm. Sci Rep. 2013; 3: 3536-43.
143. Lai J, Zhang Y, Pasquale N, Lee KB. An upconversion nanoparticle with orthogonal emissions using dual NIR excitations for controlled two-way photoswitching. Angew Chem Int Ed Engl. 2014; 53: 14419-23.
144. Ai X, Ho CJ, Aw J, Attia AB, Mu J, Wang Y, et al. In vivo covalent cross-linking of photon-converted rare-earth nanostructures for tumour localization and theranostics. Nat Commun. 2016; 7: 10432-41.
145. Vijayaraghavan P, Liu CH, Vankayala R, Chiang CS, Hwang KC. Designing multi-branched gold nanoechinus for NIR light activated dual modal photodynamic and photothermal therapy in the second biological window. Adv Mater. 2014; 26: 6689-95.
146. Wang X, Wang C, Cheng L, Lee ST, Liu Z. Noble metal coated single-walled carbon nanotubes for applications in surface enhanced Raman scattering imaging and photothermal therapy. J Am Chem Soc. 2012; 134: 7414-22.
147. Melancon MP, Zhou M, Li C. Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res. 2011; 44: 947-56.
148. Ahmad R, Fu J, He N, Li S. Advanced gold nanomaterials for photothermal therapy of cancer. J Nanosci Nanotechno. 2016; 16: 67-80.
149. Croissant J, Zink JI. Nanovalve-controlled cargo release activated by plasmonic heating. J Am Chem Soc. 2012; 134: 7628-31.
150. Hu SH, Chen YW, Hung WT, Chen IW, Chen SY. Quantum-dot-tagged reduced graphene oxide nanocomposites for bright fluorescence bioimaging and photothermal therapy monitored in situ. Adv Mater. 2012; 24: 1748-54.
151. Ding X, Liow CH, Zhang M, Huang R, Li C, Shen H, et al. Surface plasmon resonance enhanced light absorption and photothermal therapy in the second near-infrared window. J Am Chem Soc. 2014; 136: 15684-93.
152. Zhang L, Chen Y, Li Z, Li L, Saint-Cricq P, Li C, et al. Tailored synthesis of octopus-type janus nanoparticles for synergistic actively-targeted and chemo-photothermal therapy. Angew Chem Int Ed Engl. 2016; 55: 2118-21.
153. Yuan H, Fales AM, Vo-Dinh T. TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance. J Am Chem Soc. 2012; 134: 11358-61.
154. Zhu X, Feng W, Chang J, Tan YW, Li J, Chen M, et al. Temperature-feedback upconversion nanocomposite for accurate photothermal therapy at facile temperature. Nat Commun. 2016; 7: 10437-47.
155. Robinson JT, Tabakman SM, Liang Y, Wang H, Casalongue HS, Vinh D, et al. Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc. 2011; 133: 6825-31.
156. Lin J, Wang M, Hu H, Yang X, Wen B, Wang Z, et al. Multimodal-imaging-guided cancer phototherapy by versatile biomimetic theranostics with UV and ?-irradiation protection. Adv Mater. 2016; 28: 3273-9.
157. Huang P, Rong P, Lin J, Li W, Yan X, Zhang MG, et al. Triphase interface synthesis of plasmonic gold bellflowers as near-infrared light mediated acoustic and thermal theranostics. J Am Chem Soc. 2014; 136: 8307-13.
158. Huang P, Bao L, Zhang C, Lin J, Luo T, Yang D, et al. Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy. Biomaterials. 2011; 32: 9796-809.
159. Leung SJ, Kachur XM, Bobnick MC, Romanowski M. Wavelength-selective light-induced release from plasmon resonant liposomes. Adv Funct Mater. 2011; 21: 1113-21.
160. Huang P, Lin J, Li W, Rong P, Wang Z, Wang S, et al. Biodegradable gold nanovesicles with an ultrastrong plasmonic coupling effect for photoacoustic imaging and photothermal therapy. Angew Chem Int Ed. 2013; 52: 13958-64.
161. Liu T, Shi S, Liang C, Shen S, Cheng L, Wang C, et al. Iron oxide decorated MoS2 nanosheets with double pegylation for chelator-free radiolabeling and multimodal imaging guided photothermal therapy. ACS Nano. 2015; 9: 950-60.
162. Song X, Chen Q, Liu Z. Recent advances in the development of organic photothermal nano-agents. Nano Research. 2015; 8: 340-54.
163. Huang P, Gao Y, Lin J, Hu H, Liao H-S, Yan X, et al. Tumor-specific formation of enzyme-instructed supramolecular self-assemblies as cancer theranostics. ACS nano. 2015; 9: 9517-27.
164. Huang P, Rong P, Jin A, Yan X, Zhang MG, Lin J, et al. Dye-Loaded Ferritin Nanocages for Multimodal Imaging and Photothermal Therapy. Adv Mater. 2014; 26: 6401-8.
165. Xu L, Cheng L, Wang C, Peng R, Liu Z. Conjugated polymers for photothermal therapy of cancer. Polym Chem. 2014; 5: 1573-80.
166. Lovell JF, Jin CS, Huynh E, MacDonald TD, Cao W, Zheng G. Enzymatic regioselection for the synthesis and biodegradation of porphysome nanovesicles. Angew Chem Int Ed. 2012; 51: 2429-33.
167. Yue C, Liu P, Zheng M, Zhao P, Wang Y, Ma Y, et al. IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy. Biomaterials. 2013; 34: 6853-61.
168. Wang Z, Huang P, Jacobson O, Wang Z, Liu Y, Lin L, et al. Biomineralization-Inspired Synthesis of Copper Sulfide-Ferritin Nanocages as Cancer Theranostics. ACS nano. 2016; 10: 3453-60.
169. Chen Q, Liang C, Wang C, Liu Z. An imagable and photothermal "Abraxane-like" nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors. Adv Mater. 2015; 27: 903-10.
170. Lovell JF, Jin CS, Huynh E, Jin H, Kim C, Rubinstein JL, et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nature Mater. 2011; 10: 324-32.
171. Chen Q, Ke H, Dai Z, Liu Z. Nanoscale theranostics for physical stimulus-responsive cancer therapies. Biomaterials. 2015; 73: 214-30.
172. Kim H, Chung K, Lee S, Kim DH, Lee H. Near-infrared light-responsive nanomaterials for cancer theranostics. WIREs Nanomed Nanobiotechnol. 2016; 8: 23-45.
173. Kim C, Favazza C, Wang LV. In vivo photoacoustic tomography of chemicals: high-resolution functional and molecular optical imaging at new depths. Chem Rev. 2010; 110: 2756-82.
174. Fried NM, Burnett AL. Novel methods for mapping the cavernous nerves during radical prostatectomy. Nat Rev Urol. 2015; 12: 451-60.
175. Rozycki GS. Surgeon-performed ultrasound: its use in clinical practice. Ann Surg. 1998; 228: 16-28.
176. Egan G, Healy D, O'Neill H, Clarke-Moloney M, Grace PA, Walsh SR. Ultrasound guidance for difficult peripheral venous access: systematic review and meta-analysis. Emerg Med J. 2013; 30: 521-6.
177. Wang LV, Gao L. Photoacoustic microscopy and computed tomography: from bench to bedside. Annu Rev Biomed Eng. 2014; 16: 155-85.
178. Kim J, Lee D, Jung U, Kim C. Photoacoustic imaging platforms for multimodal imaging. Ultrasonography. 2015; 34: 88-97.
179. Nie L, Chen X. Structural and functional photoacoustic molecular tomography aided by emerging contrast agents. Chem Soc Rev. 2014; 43: 7132-70.
180. Akers WJ, Kim C, Berezin M, Guo K, Fuhrhop R, Lanza GM, et al. Noninvasive photoacoustic and fluorescence sentinel lymph node identification using dye-loaded perfluorocarbon nanoparticles. ACS nano. 2010; 5: 173-82.
181. Dragulescu-Andrasi A, Kothapalli SR, Tikhomirov GA, Rao J, Gambhir SS. Activatable oligomerizable imaging agents for photoacoustic imaging of furin-like activity in living subjects. J Am Chem Soc. 2013; 135: 11015-22.
182. Ke H, Wang J, Dai Z, Jin Y, Qu E, Xing Z, et al. Gold-nanoshelled microcapsules: a theranostic agent for ultrasound contrast imaging and photothermal therapy. Angew Chem Int Ed. 2011; 50: 3017-21.
183. Li K, Liu B. Polymer-encapsulated organic nanoparticles for fluorescence and photoacoustic imaging. Chem Soc Rev. 2014; 43: 6570-97.
184. Ho CJ, Balasundaram G, Driessen W, McLaren R, Wong CL, Dinish US, et al. Multifunctional photosensitizer-based contrast agents for photoacoustic imaging. Sci Rep. 2014; 4: 5342-8.
185. Pu K, Shuhendler AJ, Jokerst JV, Mei J, Gambhir SS, Bao Z, et al. Semiconducting polymer nanoparticles as photoacoustic molecular imaging probes in living mice. Nature Nanotech. 2014; 9: 233-9.
186. Fan Q, Cheng K, Hu X, Ma X, Zhang R, Yang M, et al. Transferring biomarker into molecular probe: melanin nanoparticle as a naturally active platform for multimodality imaging. J Am Chem Soc. 2014; 136: 15185-94.
187. Zhou Y, Wang D, Zhang Y, Chitgupi U, Geng J, Wang Y, et al. A phosphorus phthalocyanine formulation with intense absorbance at 1000 nm for deep optical imaging. Theranostics. 2016; 6: 688-97.
188. Liu Y, Ai K, Lu L. Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications. Acc Chem Res. 2012; 45: 1817-27.
189. Seegenschmiedt MH, Makoski HB, Trott KR, and Brady LW. Radiotherapy for non-malignant disorders. In: Brady LW, Combs SE, Lu JJ, ed. Medical radiology-radiation oncology. New York: Springer; 2008, 147-59.
190. Liu Y, Ai K, Liu J, Yuan Q, He Y, Lu L. A high-performance ytterbium-based nanoparticulate contrast agent for in vivo X-ray computed tomography imaging. Angew Chem Int Ed. 2012; 51: 1437-42.
191. Rabin O, Manuel Perez J, Grimm J, Wojtkiewicz G, Weissleder R. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nature Mater. 2006; 5: 118-22.
192. Sun X, Cai W, Chen X. Positron emission tomography imaging using radiolabeled inorganic nanomaterials. Acc Chem Res. 2015; 48: 286-94.
193. Shen B, Jeon J, Palner M, Ye D, Shuhendler A, Chin FT, et al. Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-triggered nanoaggregation probe. Angew Chem Int Ed. 2013; 52: 10511-4.
194. Cornelissen B, Able S, Kersemans V, Waghorn PA, Myhra S, Jurkshat K, et al. Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors. Biomaterials. 2013; 34: 1146-54.
195. Wu Y, Sun Y, Zhu X, Liu Q, Cao T, Peng J, et al. Lanthanide-based nanocrystals as dual-modal probes for SPECT and X-ray CT imaging. Biomaterials. 2014; 35: 4699-705.
196. Rieffel J, Chen F, Kim J, Chen G, Shao W, Shao S, et al. Hexamodal imaging with porphyrin-phospholipid-coated upconversion nanoparticles. Adv Mater. 2015; 27: 1785-90.
197. Fan W, Shen B, Bu W, Chen F, Zhao K, Zhang S, et al. Rattle-structured multifunctional nanotheranostics for synergetic chemo-/radiotherapy and simultaneous magnetic/luminescent dual-mode imaging. J Am Chem Soc. 2013; 135: 6494-503.
198. Mieszawska AJ, Mulder WJ, Fayad ZA, Cormode DP. Multifunctional gold nanoparticles for diagnosis and therapy of disease. Mol Pharm. 2013; 10: 831-47.
199. Boschi F, Calderan L, D'Ambrosio D, Marengo M, Fenzi A, Calandrino R, et al. In vivo 18F-FDG tumour uptake measurements in small animals using Cerenkov radiation. Eur J Nucl Med Mol Imaging. 2011; 38: 120-7.
200. Zhang R, D'Souza A V, Gunn JR, Esipova TV, Vinogradov SA, Glaser AK, et al. Cherenkov-excited luminescence scanned imaging. Opt Lett. 2015; 40: 827-30.
201. Glaser AK, Zhang R, Gladstone DJ, Pogue BW. Optical dosimetry of radiotherapy beams using Cherenkov radiation: the relationship between light emission and dose. Phys Med Biol. 2014; 59: 3789-811.
202. Roussakis Y, Zhang R, Heyes G, Webster G, Mason S, Green S, et al. Real-time Cherenkov emission portal imaging during CyberKnife(R) radiotherapy. Phys Med Biol. 2015; 60: 19-25.
203. Thorek DL, Das S, Grimm J. Molecular imaging using nanoparticle quenchers of Cerenkov luminescence. Small. 2014; 10: 3729-34.
204. Chan EM, Han G, Goldberg JD, Gargas DJ, Ostrowski AD, Schuck PJ, et al. Combinatorial discovery of lanthanide-doped nanocrystals with spectrally pure upconverted emission. Nano Lett. 2012; 12: 3839-45.
205. Liu C, Hou Y, Gao M. Are rare-earth nanoparticles suitable for in vivo applications? Adv Mater. 2014; 26: 6922-32.
206. Sun Y, Feng W, Yang P, Huang C, Li F. The biosafety of lanthanide upconversion nanomaterials. Chem Soc Rev. 2015; 44: 1509-25.